Barbara J. Schwarzentraub - May 31, 2024 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Barbara J. Schwarzentraub by Power of Attorney
Stock symbol
CNMD
Transactions as of
May 31, 2024
Transactions value $
$0
Form type
4
Date filed
6/4/2024, 09:05 PM
Previous filing
May 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +302 +8.48% $0.00 3.87K May 31, 2024 Direct
holding CNMD Common Stock 1.44K May 31, 2024 by The Barbara J. Schwarzentraub Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -302 -100% $0.00* 0 May 31, 2024 Common Stock 302 $0.00 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +5.5K $0.00 5.5K Jun 3, 2024 Common Stock 5.5K $77.18 Direct F2
transaction CNMD Rsus (restricted Stock Units) Award $0 +479 $0.00 479 Jun 3, 2024 Common Stock 479 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.